Richard Upton is a General Partner of Harbor Light Capital Partners, an early-stage venture capital firm.  Previously, he was founder and President of Upton Advisors, a boutique investment bank serving middle market and emerging healthcare companies. Mr. Upton has been advising early-stage companies since 1992 both as an investment banker for Salomon Brothers and later as an independent advisor. Mr. Upton has completed engagements representing aggregate transaction values in excess of $5 billion. 

Mr. Upton currently serves on the Boards of Alcyone Lifesciences, Carmell Therapeutics and Medicinal Genomics Corp., and previously served on the Boards of Home Diagnostics, Inc. (NASDAQ: HDIX – acquired by Nipro Corporation), Courtagen Life Sciences and Castlewood Surgical. Mr. Upton is a member of the Investment Committee of the New Hampshire Charitable Foundation, and is former Chairman of The Pine Hill Waldorf School. Mr. Upton is a founding member of Northeast Angels, an early-stage angel investing group. He has also been a youth hockey coach since 2001. Mr. Upton received his MBA degree from The Darden School at the University of Virginia and a dual BA degree in Economics and English from Amherst College.